NCT04933721Phase 3Enrolling by invitation

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

Study sponsor: BioCryst Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-08Estimated
Enrollment · participants139Estimated
Source updated2025-12-23Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Enrolling by invitation.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview